| scholarly article | Q13442814 |
| P2093 | author name string | Huang X | |
| Nichols DE | |||
| Marona-Lewicka D | |||
| Cozzi NV | |||
| Frescas S | |||
| P2860 | cites work | 5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine | Q24680216 |
| 5-iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine | Q28268394 | ||
| Structure-activity studies on amphetamine analogs using drug discrimination methodology | Q28269895 | ||
| Mechanisms of effects of d-fenfluramine on brain serotonin metabolism in rats: uptake inhibition versus release | Q28339453 | ||
| Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA). | Q33996413 | ||
| Structural variation and (+)-amphetamine-like discriminative stimulus properties | Q34129433 | ||
| Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan | Q34323337 | ||
| Drug discrimination studies with MDMA and amphetamine | Q34560372 | ||
| Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA). | Q34997151 | ||
| Pharmacological approaches to appetite suppression | Q37773156 | ||
| Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system | Q38165674 | ||
| Neurobiology of an anorectic drug: fenfluramine | Q39739956 | ||
| Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine | Q39765834 | ||
| Drug treatment and obesity | Q40253392 | ||
| Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity | Q40468890 | ||
| Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in rats | Q41140132 | ||
| Comparative serotonin neurotoxicity of the stereoisomers of fenfluramine and norfenfluramine | Q41197417 | ||
| Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum | Q42478887 | ||
| MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons | Q48121118 | ||
| Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes | Q48250052 | ||
| Single- and multiple-dose kinetics of d-fenfluramine in rats given anorectic and toxic doses | Q48533689 | ||
| Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotonergic mechanisms | Q48579995 | ||
| Dexfenfluramine neurotoxicity in brains of non-human primates | Q48609779 | ||
| Immunohistochemical study of short- and long-term effects of DL-fenfluramine on the serotonergic innervation of the rat hippocampal formation | Q48794164 | ||
| d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. | Q51596388 | ||
| Reinforcing effects of certain serotonin-releasing amphetamine derivatives. | Q52203594 | ||
| Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. | Q52260167 | ||
| Comparison of the effects of 6-chloro-2-aminotetralin and of Org 6582, a related chloroamphetamine analog, on brain serotonin metabolism in rats | Q56763433 | ||
| The regeneration of d,l-fenfluramine-destroyed serotonergic nerve terminals | Q70493775 | ||
| Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms | Q71668701 | ||
| d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release | Q72426569 | ||
| The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine | Q73049372 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurotoxicity | Q3338704 |
| P304 | page(s) | 709-715 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential | |
| P478 | volume | 59 |
| Q34199734 | Aminoindanes--the next wave of 'legal highs'? |
| Q37268774 | Appetite suppressants, cardiac valve disease and combination pharmacotherapy |
| Q24641896 | Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction |
| Q48821854 | Improving amphetamine therapeutic selectivity: N,N-dimethyl-MTA has dopaminergic effects and does not produce aortic contraction |
| Q24646869 | Serotonergic drugs and valvular heart disease |
| Q28138124 | Serotonin transporters, serotonin release, and the mechanism of fenfluramine neurotoxicity |
| Q34142899 | Therapeutic and adverse actions of serotonin transporter substrates |
Search more.